Quarterly Call Option Transactions in Akebia Therapeutics, Inc. (AKBA)
This table provides information about the institutional ownership of Akebia Therapeutics, Inc. (AKBA) during . The information is specifically focused on institutions that hold call options of Akebia Therapeutics, Inc..
Calls Purchased
Calls Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q3 2021 | 8,000 | 0 | 8,000 | 135,200 | 39,300 | 174,500 | -166,500 | |
| Q4 2021 | 0 | 869,200 | 869,200 | 1,142,900 | 48,000 | 1,190,900 | -321,700 | |
| Q1 2022 | 972,200 | 1,333,111 | 2,305,311 | 34,200 | 19,400 | 53,600 | 2,251,711 | |
| Q2 2022 | 6,000 | 0 | 6,000 | 239,700 | 3,038,200 | 3,277,900 | -3,271,900 | |
| Q3 2022 | 1,100 | 40,700 | 41,800 | 90,000 | 0 | 90,000 | -48,200 | |
| Q4 2022 | 14,100 | 14,300 | 28,400 | 20,500 | 0 | 20,500 | 7,900 | |
| Q1 2023 | 72,600 | 39,800 | 112,400 | 14,400 | 0 | 14,400 | 98,000 | |
| Q2 2023 | 34,600 | 0 | 34,600 | 19,800 | 0 | 19,800 | 14,800 | |
| Q3 2023 | 59,800 | 79,200 | 139,000 | — | 139,000 | |||
| Q4 2023 | 15,300 | 0 | 15,300 | 5,100 | 0 | 5,100 | 10,200 | |
| Q1 2024 | 544,000 | 10,000 | 554,000 | 29,900 | 0 | 29,900 | 524,100 | |
| Q2 2024 | — | 339,000 | 0 | 339,000 | -339,000 | |||
| Q3 2024 | 35,700 | 48,100 | 83,800 | 346,400 | 0 | 346,400 | -262,600 | |